October 19, 2006
By:
Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
New York, NY (Oct. 19)-Pfizer, Inc. plans to implement a new company-wide cost-cutting initiative in 2007 as part of strategy to improve operating performance. The cuts are in addition to a previous cost-reduction program that Pfizer launched in 2005.
|
October 12, 2006
By:
Brianne Harrison
ePT--the Electronic Newsletter of Pharmaceutical Technology
Langley, BC, Canada (Oct. 10)-AnorMED Inc. has determined that Genzyme's US $580 million offer to acquire all outstanding AnorMED shares at US $13.50 a share is a "superior proposal."
|
September 21, 2006
By:
Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck KGaA has agreed to buy a majority stake in the European biotechnology company Serono SA for CHF 16.6 billion ($13.3 billion).
|
September 21, 2006
By:
Brianne Harrison
ePT--the Electronic Newsletter of Pharmaceutical Technology
Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America upon the resignation of Peter R. Dolan.
|
September 14, 2006
By:
Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
Chemir Analytical Services has launched IQsynthesis, formerly known as Gateway Chemical Technology, Inc. Chemir acquired Gateway Chemical Technology, which provides custom synthesis and process development services, in May 2006.
|
April 1, 2010
Pharmaceutical Technology Europe
T cell therapy is an investigational approach that is being assessed for the patient?specific treatment of cancer.
|
|
